130
Participants
Start Date
December 8, 2023
Primary Completion Date
July 31, 2030
Study Completion Date
July 31, 2030
XEN45 Glaucoma Treatment System
Ab interno implantation
Trabeculectomy
Surgical Intervention
RECRUITING
Peking University people s hospital /ID# 265493, Beijing
RECRUITING
Peking University Third Hospital /ID# 243994, Beijing
RECRUITING
Beijing Tongren Hospital Affiliated To Capital Medical University /ID# 244055, Beijing
RECRUITING
Qingdao Eye Hospital Of Shandong First Medical University /ID# 243992, Qingdao
RECRUITING
Tianjin Eye Hospital /ID# 243997, Tianjin
RECRUITING
The Second Affiliated Hospital of Zhejiang University School of Medicine /ID# 243996, Hangzhou
RECRUITING
The First Affiliated Hospital Of Fujian Medical University /ID# 244004, Fuzhou
COMPLETED
Xiamen Eye Center of Xiamen University /ID# 244000, Xiamen
RECRUITING
Tongji Hospital Tongji Medical College of HUST /ID# 243998, Wuhan
RECRUITING
Zhongshan Ophthalmic Center,SunYat-Sen University /ID# 243843, Guangzhou
RECRUITING
Shenzhen Eye Hospital /ID# 244001, Shenzhen
RECRUITING
West China Hospital, Sichuan University /ID# 243999, Chengdu
Lead Sponsor
AbbVie
INDUSTRY